Cargando…
Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial. Italian Chemoprevention Group.
The combination of tamoxifen and transdermal hormone replacement therapy (HRT) may potentially reduce risks and side-effects of either agent, but an adverse interaction could attenuate their beneficial effects. We assessed the effects of their combination on cardiovascular risk factors within a prev...
Autores principales: | Decensi, A., Robertson, C., Rotmensz, N., Severi, G., Maisonneuve, P., Sacchini, V., Boyle, P., Costa, A., Veronesi, U. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063049/ https://www.ncbi.nlm.nih.gov/pubmed/9744493 |
Ejemplares similares
-
The Italian Tamoxifen Prevention Trial
por: Bonanni, B., et al.
Publicado: (1999) -
Chemoprevention: beyond tamoxifen
por: Cuzick, J
Publicado: (2005) -
The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trial
por: Lazzeroni, M, et al.
Publicado: (2008) -
Breast cancer chemoprevention: beyond tamoxifen
por: Fabian, Carol J
Publicado: (2001) -
Tamoxifen reduces plasma homocysteine levels in healthy women.
por: Cattaneo, M., et al.
Publicado: (1998)